BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23574297)

  • 1. Mycophenolate use in dermatology: a clinical audit.
    Li J; Chong AH; Green J; Kelly R; Baker C
    Australas J Dermatol; 2013 Nov; 54(4):296-302. PubMed ID: 23574297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil as therapy for pyoderma gangrenosum.
    Eaton PA; Callen JP
    Arch Dermatol; 2009 Jul; 145(7):781-5. PubMed ID: 19620559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.
    Li J; Kelly R
    J Am Acad Dermatol; 2013 Oct; 69(4):565-9. PubMed ID: 23850090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil and skin diseases.
    Hartmann M; Enk A
    Lupus; 2005; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil in pyoderma gangrenosum.
    Lee MR; Cooper AJ
    J Dermatolog Treat; 2004 Sep; 15(5):303-7. PubMed ID: 15370398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum.
    Hohenleutner U; Mohr VD; Michel S; Landthaler M
    Lancet; 1997 Dec; 350(9093):1748. PubMed ID: 9413469
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum.
    Daniels NH; Callen JP
    Arch Dermatol; 2004 Dec; 140(12):1427-9. PubMed ID: 15611417
    [No Abstract]   [Full Text] [Related]  

  • 8. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum.
    Nousari HC; Lynch W; Anhalt GJ; Petri M
    Arch Dermatol; 1998 Dec; 134(12):1509-11. PubMed ID: 9875186
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyoderma gangrenosum associated with Wegener's granulomatosis: partial response to mycophenolate mofetil.
    Le Hello C; Bonte I; Mora JJ; Verneuil L; Noël LH; Guillevin L
    Rheumatology (Oxford); 2002 Feb; 41(2):236-7. PubMed ID: 11886982
    [No Abstract]   [Full Text] [Related]  

  • 10. An analysis of the dermatological uses of mycophenolate mofetil in a tertiary hospital.
    George L; Hamann I; Chen K; Choi J; Fernandez-Peñas P
    J Dermatolog Treat; 2015 Feb; 26(1):63-6. PubMed ID: 24286467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.
    Hrin ML; Bashyam AM; Huang WW; Feldman SR
    Int J Dermatol; 2021 Dec; 60(12):e486-e492. PubMed ID: 33739458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate in dermatology.
    Liu V; Mackool BT
    J Dermatolog Treat; 2003 Dec; 14(4):203-11. PubMed ID: 14660264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis.
    Gilmour E; Stewart DG
    Br J Dermatol; 2001 Feb; 144(2):397-400. PubMed ID: 11251582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis.
    Murray ML; Cohen JB
    Clin Exp Dermatol; 2007 Jan; 32(1):23-7. PubMed ID: 17059445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients].
    Ballester I; Silvestre JF; Pérez-Crespo M; Lucas A
    Actas Dermosifiliogr; 2009 Dec; 100(10):883-7. PubMed ID: 20038365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy-resistant pyoderma gangrenosum--treatment with mycophenolate mofetil and cyclosporine A].
    Michel S; Hohenleutner U; Mohr V; Landthaler M
    Hautarzt; 1999 Jun; 50(6):428-31. PubMed ID: 10427512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil is effective in the treatment of atopic dermatitis.
    Grundmann-Kollmann M; Podda M; Ochsendorf F; Boehncke WH; Kaufmann R; Zollner TM
    Arch Dermatol; 2001 Jul; 137(7):870-3. PubMed ID: 11453805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
    Haeck IM; Knol MJ; Ten Berge O; van Velsen SG; de Bruin-Weller MS; Bruijnzeel-Koomen CA
    J Am Acad Dermatol; 2011 Jun; 64(6):1074-84. PubMed ID: 21458107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix.
    Wollina U; Karamfilov T
    J Eur Acad Dermatol Venereol; 2000 May; 14(3):187-90. PubMed ID: 11032062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil.
    Hantash B; Fiorentino D
    Arch Dermatol; 2006 Jan; 142(1):109-10. PubMed ID: 16415398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.